Exploration of complement as an FSHD biomarker showed that C3 and C4b were significantly elevated in FSHD populations, while a composite score including a panel of four complement proteins showed promise as an FSHD biomarker and supported a role for complement activation in FSHD. Here, C3 is linked to facioscapulohumeral muscular dystrophy.